HLTH
Not rated
No published distribution safety rating is available.
ETF Comparison
A head-to-head comparison of Tema Healthcare AI ETF and Vanguard Health Care ETF covering yield, cost, risk, and income potential.
Updated November 6, 2026
No track record yet. HLTH launched within the last six months. The forward distribution rate is left blank until a payout is published.
How these figures are calculated: methodology.
Compare the same available dates. Add a ticker or benchmark below; these controls change the chart only. The snapshot and article describe the original comparison.
Interactive history loads here. The snapshot and period returns remain available when chart history cannot be loaded.
An estimate of distribution reliability, not price or principal safety, a probability, or a guarantee. Score methodology.
Not rated
No published distribution safety rating is available.
Safe
High confidence
Score snapshot as of . Method 1.11.
| Metric | ||
|---|---|---|
| Full name | Tema Healthcare AI ETF | Vanguard Health Care ETF |
| Issuer | Tema ETFs | Vanguard |
| Last Close | $26.95 as of November 6, 2026 | $341.23 as of November 6, 2026 |
| Distribution rate | — | 1.14% |
| Trailing 12-month yield | — | 1.35% |
| Distribution Safety Score™ | — | 100 |
| Safety-Adjusted Yield | — | 1.14% |
| Expense ratio | 0.75% | 0.09% |
| AUM | $11.7M | $20.7B |
| Distribution frequency | None | Quarterly |
| Underlying index | Actively managed (no tracked index recorded) | MSCI US Investable Market Health Care 25/50 Index |
| Objective | Seeks long-term capital appreciation through an actively managed portfolio of companies applying artificial intelligence across healthcare — including AI-driven drug discovery, diagnostics, medical imaging, medical devices, and healthcare IT platforms. | Tracks the MSCI US Investable Market Health Care 25/50 Index. |
| Asset class | Equity | Equity |
| Inception date | 07/21/2026 | 01/26/2004 |
| Beta | — | 0.57 |
| Last dividend | — | $0.969 |
| Ex-dividend date | — | 09/23/2026 |
— Distribution rate, Safety-Adjusted Yield, last dividend, and ex-dividend date are not yet available because HLTH launched July 2026; these fields will populate after the first distribution.
100% reinvested · ex-date convention. Period returns use this fixed assumption, independent of chart settings. YTD and 1Y are cumulative period returns; 3Y, 5Y, and 10Y are annualized. The shared Since-start window is annualized only when it covers at least one year.
HLTH has lagged VHT over the year to date, posting a 5.60% total return against 19.75%. VHT has been the steadier holding, though — annualized volatility of 17.8% against 35.9% for HLTH. Figures are total returns: price change plus every distribution reinvested.
| Symbol | YTD cumulative | Since Jul 2026 | Volatility | Sharpe | Sortino | Max drawdown |
|---|---|---|---|---|---|---|
| HLTH | 5.60% | 5.60% | 35.9% | 0.39 | 0.52 | -12.6% |
| VHT | 19.75% | 13.35% | 17.8% | 2.10 | 3.55 | -5.7% |
Total return with all distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date), split-adjusted, as of November 5, 2026. YTD and 1Y are cumulative period returns; 3Y, 5Y, and 10Y are annualized. The shared Since-start window is annualized only when it covers at least one year. “Since Jul 2026” measures every fund from July 21, 2026 — the start of shared available history — so all funds share one comparison window. Volatility is the annualized standard deviation of daily total returns over the shared window since Jul 2026. Sharpe and Sortino divide the annualized return in excess of the risk-free rate by, respectively, that volatility and the downside deviation (both over the shared window since Jul 2026) — higher is better. Max drawdown is the largest peak-to-trough total-return decline over the same window — shallower is better.
HLTH (Tema Healthcare AI ETF) has no distribution rate on file and its distribution frequency is None. HLTH is not a payer. The blank yield is not a zero yield.
Projections assume the current yield and share price remain constant. Actual results will vary.
Bottom lineWe won't call this one: HLTH launched July 2026, so there is not yet a track record to compare. Compare the strategy, cost and holdings in the sections above and treat any performance figures for the newer ETF as provisional. What is already clear from the numbers above: the two do not cost the same — VHT charges 0.09% against 0.75% for HLTH, and on funds tracking the same thing that gap compounds every year you hold.
See how much monthly income a hypothetical investment would generate in each ETF at current yields.
ETFs and AUM reflect what Dividend Vision tracks — the issuer's full lineup may be larger.
Tema ETFs is known for offering thematically focused and income-oriented strategies that target specific industries and trends rather than broad market exposure. The issuer's lineup spans both income-generating funds and thematic investments centered on sectors such as defense, healthcare, technology, and infrastructure, with tickers including ARMY, CANC, DSPY, HLTH, LAZR, NASA, and VOLT. Tema's approach appeals to investors seeking targeted exposure to niche market segments, combining specialized industry focus with dividend and yield strategies.
See our curated list of related YouTube videos on HLTH.
ETFs and AUM reflect what Dividend Vision tracks — the issuer's full lineup may be larger.
Vanguard is one of the largest and most established ETF issuers, known for low-cost, broadly diversified fund offerings built on passive indexing principles. Their lineup spans multiple asset classes and strategies, including core equity and bond index funds, dividend-focused portfolios, ESG-screened options, factor-based strategies, sector exposure, target-date retirement funds, and international investments across developed and emerging markets. The platform is characterized by its emphasis on accessibility and cost efficiency across a comprehensive range of fund families, serving both individual investors seeking broad market exposure and those pursuing specific income, sustainability, or thematic objectives.
See our curated list of related YouTube videos on VHT.
HLTH (Tema Healthcare AI ETF) and VHT (Vanguard Health Care ETF) are both ETFs, but they take different approaches.
VHT currently shows a 1.14% distribution yield. HLTH has not yet established a full distribution history, so a comparable yield figure is not available.
VHT is cheaper with an expense ratio of 0.09% compared to 0.75%.
VHT has $20.7B in assets vs $11.7M for HLTH, but HLTH only launched July 2026 — AUM comparisons will become more meaningful as it builds a track record.
Positions that appear in every fund's top 10. Issuers disclose only the largest weights, so this captures the overlap of the concentrated end of each book — not the full portfolios.
| Position | HLTH | VHT |
|---|---|---|
| TMO Thermo Fisher Scientific Inc |
On a $10,000 investment at current distribution rates, HLTH has no reported distribution yield yet, so a cash estimate is not available, while VHT would pay about $114.00 a year (about $28.50 per quarterly distribution).
Over 10 years on $10,000, HLTH would cost approximately $750 in fees vs $90 for VHT (simplified, not compounded). The $660.00 difference may be offset by yield or performance.
HLTH is an actively managed ETF built around healthcare exposure, while VHT tracks MSCI US Investable Market Health Care 25/50 Index.
HLTH is managed by Tema ETFs (launched 07/21/2026) with $11.7M in assets. VHT is managed by Vanguard (launched 01/26/2004) with $20.7B in assets.
VHT currently reports a distribution yield, while HLTH has not yet established a full distribution history. A direct income comparison is not yet meaningful — check back once both funds have published several consecutive distributions.
HLTH (Tema Healthcare AI ETF) is an actively managed ETF built around healthcare exposure, while VHT (Vanguard Health Care ETF) tracks MSCI US Investable Market Health Care 25/50 Index. They are issued by Tema ETFs and Vanguard respectively.
Yes. Their disclosed top-10 holdings share only 1 position, so combining both adds mostly distinct underlying names — see the holdings-overlap section above. Overlap outside the disclosed top 10 can still exist.
HLTH has an expense ratio of 0.75% while VHT charges 0.09%. Lower fees mean more of your investment returns stay in your pocket over time.
At current distribution rates, HLTH does not pay distributions, so there is no cash income to estimate. $10,000 in VHT would pay about $114.00 a year (about $28.50 per quarterly distribution).
HLTH has lagged VHT over the year to date, posting a 5.60% total return against 19.75%. VHT has been the steadier holding, though — annualized volatility of 17.8% against 35.9% for HLTH. Figures are total returns: price change plus every distribution reinvested. Past performance does not guarantee future results.
Generated October 31, 2026.
Figures quoted in this analysis are from its generation date and may lag the live snapshot table above, which always shows the latest data.
HLTH and VHT are both healthcare equity ETFs, but they differ fundamentally in approach and scope. VHT is a broad index fund tracking the MSCI US healthcare universe across all market capitalizations, while HLTH is an actively managed fund focused narrowly on companies deploying artificial intelligence within healthcare. VHT has been operating since 01/26/2004 and holds $20.7B in assets; HLTH launched 3 months and holds $11.7M.
The largest distinction is strategy: VHT is a passive index tracker holding the full breadth of US healthcare stocks, whereas HLTH is an actively managed fund concentrated in AI-applied healthcare. This drives everything else. VHT's 0.09% expense ratio is substantially lower than HLTH's 0.75%, a 0.66 percentage-point gap typical of index versus active management. The asset-base gap is dramatic—VHT's $20.7B exceeds HLTH's $11.7M, reflecting VHT's two-decade track record versus HLTH's recent launch.
If you want affordable, diversified US healthcare exposure with a 20-year track record and a 1.14% payout, VHT aligns with that profile. Past performance does not predict future results.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.
The metrics behind this comparison, explained in the Academy.
These comparisons follow the Dividend Vision methodology.